Home       Market Dynamics     Sector Analysis     Company Insights     AI Investing     Strategies     Contact Us     Login             

Amgen (AMGN) Stock Price Prediction and News Highlight
Sat. Nov 8, 2025

Amgen is experiencing strong product sales growth, with a notable 12% increase in sales, driven by effective drug development. The effectiveness of its cardiovascular drug Repatha is a leading factor contributing to market confidence, complemented by a robust R&D investment strategy that promises future innovations. However, ongoing costs related to the development of experimental drugs like MariTide pose financial challenges. Nevertheless, Amgen's extensive research and development pipeline remains a key asset enhancing its competitive position.

The price action of Amgen (AMGN) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.7 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for AMGN since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.7, and the negative at 0 on 2025-11-08. The forces of and () will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), Valuation Sentiment (1.1), and Sentiment towards Fundamentals (3) will drive up the price.

The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band.

Earning Release: 2026-02-02 10:00, EPS: $12.94, P/E: 24.74

AMGN
DateAttentionPricePrice
Level
ChangeSMA10
Trend
Trend
Sentiment
Hourly
Trend
Hourly
StdDev
Market
Sentiment
ActionPFund.News
Sentiment
2025-11-080%(0%)    0    0%    0.7          3    -1   
2025-11-070%(0%)    0    0%    0.3          2.6    -1   
2025-11-060%(0%)    0    0%    0.3          2.7    -1   
2025-11-050%(0%)    0    0%    0.4          3.1    -1   
2025-11-040%(0%)    0    0%    0.2          2.3    7   
2025-11-030%(0%)    0    0%    -0.1          0.6    -1   
2025-11-020%(0%)    0    0%    -0.1          0.4    -1   
2025-11-010%(0%)    0    0%    -0.1          0.4    -1   
2025-10-310%(0%)    0    0%    -0.1          0.4    -1   
2025-10-300%(0%)    0    0%    -0.3          -1    -1   
 
Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position.
Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force.

2025-11-08 17:03:22 Amgen operates in a competitive biotech landscape, navigating market pressures while leveraging its product portfolio to maintain a leading position.
2025-11-08 17:03:22 Amgen's impressive R&D pipeline is a significant factor contributing to its positive future prospects and competitive advantages in the industry.
2025-11-08 17:03:22 The stock of Amgen is considered undervalued compared to sector peers, presenting an attractive investment opportunity in the biotech market.
2025-11-08 17:03:22 Amgen shows strong sales growth and positive financial outlook, with raised full-year guidance indicating resilient growth despite challenges.
2025-11-08 17:03:22 Amgen's Repatha demonstrates significant effectiveness in reducing risks of major adverse cardiovascular events, highlighting advancements in drug development and patient treatment options.


About   Contact Us  
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA